Nobuyuki Shimozawa

Prof. Nobuyuki Shimozawa


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 October 2013 in neurogenetics
Verified
Journal Article
Closed access
PDF file
COChihiro Ohba
Chihiro Ohba
HOHitoshi Osaka
Hitoshi Osaka
MIMizue Iai
Mizue Iai
SYSumimasa Yamashita
Sumimasa Yamashita
YSYume Suzuki
Yume Suzuki
HSHirotomo Saitsu
Hirotomo Saitsu

8 March 2007 in Journal of Inherited Metabolic Disease
Verified
Journal Article
Closed access
PDF file
NSNobuyuki Shimozawa
Nobuyuki Shimozawa

1 March 2017 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
STShigeo Takashima
Shigeo Takashima
KTKayoko Toyoshi
Kayoko Toyoshi
TITakahiro Itoh
Takahiro Itoh
NKNaomi Kajiwara
Naomi Kajiwara
AHAyako Honda
Ayako Honda
NSNobuyuki Shimozawa
Nobuyuki Shimozawa

Verified
Journal Article
Open access
PDF file
NSNobuyuki Shimozawa
Nobuyuki Shimozawa
STShigeo Takashima
Shigeo Takashima
HKHiroki Kawai
Hiroki Kawai
KKKazuo Kubota
Kazuo Kubota
HSHideo Sasai
Hideo Sasai
HOHidenori Ohnishi
Hidenori Ohnishi
We established a diagnostic system for adrenoleukodystrophy (ALD) and peroxisomal disorders (PD) over 35 years ago in Japan, and have diagnosed 237 families with ALD and more than 100 cases of PD other than ALD using biochemical and molecular analyses. In particular, since the only treatment for the cerebral form of ALD is hematopoietic stem cell transplantation at an early stage of onset, we have developed a protocol for the rapid diagnosis of ALD that can provide the measurements of the levels of very-long-chain fatty acids in the serum and genetic analysis within a few days. In addition, to improve the prognosis of patients with ALD, we are working on the detection of pre-symptomatic patients by familial analysis from the proband, and the introduction of newborn screening. In this review, we introduce the diagnostic and newborn screening approaches for ALD and PD in Japan.

17 August 2011 in Molecular Medicine Reports
Verified
Journal Article
Open access
PDF file
NSNobuyuki Shimozawa
Nobuyuki Shimozawa
SKSachi Kozawa
Sachi Kozawa
AHAyako Honda
Ayako Honda
NKNaomi Kajiwara
Naomi Kajiwara
YTYasuhiko Takemoto
Yasuhiko Takemoto
SNShigeru Nakashima
Shigeru Nakashima
Peroxisomes catalyze a range of essential metabolic functions, mainly related to lipid metabolism. However, their roles in obesity have yet to be clarified. The aim of this study was to investigate the correlation between obesity and peroxisomal lipid metabolism, particularly very long-chain fatty acid (VLCFA) metabolism, gene expression of peroxisomal beta-oxidation enzymes, peroxisomal ATP-binding cassette (ABC) transporter adrenoleukodystrophy (ABCD1) gene and its related gene, ABCD2, the elongation of the VLCFA (ELOVL) gene family and the transcriptional factors involved in the regulation of these genes, including peroxisome proliferator-activated receptor alpha (PPAR alpha) and sterol regulatory element-binding protein. These factors were analyzed in livers from mice fed a high-fat diet (HFD) or a regular diet (RD) for 20 weeks. Furthermore, the amounts of plasma saturated and unsaturated fatty acids, including VLCFAs, were measured. A HFD induced hepatic gene expression of not only hydroxysteroid 17-beta dehydrogenase 4 (HSD17b4) and sterol carrier protein 2 (SCP2) in peroxisomal beta-oxidation enzymes but also of ELOVL1, 2, 5 and 6, which are involved in the elongation of saturated and unsaturated VLCFAs. Furthermore, ABCD2 mRNA prominently increased in the HFD mice. The transcriptional regulator of these genes, PPAR alpha, was also up-regulated in the HFD mice. VLCFA ratios including C24:0/C22:0, C25:0/C22:0 and C26:0/C22:0 are the most significant diagnostic markers of inherited peroxisomal diseases. These ratios were found to be low in the plasma of the HFD mice compared with the RD mice. The results suggest that HFD activates hepatic peroxisomal VLCFA metabolism, and may provide useful fundamental information to explain the role of peroxisomal function in obesity and lifestyle-related diseases.

1 October 2011 in Brain and Development
Verified
Journal Article
Closed access
NSNobuyuki Shimozawa
Nobuyuki Shimozawa